Piper Sandler’s Q1 DCM Advisory Surges as Bank M&A Slows
Piper Sandler’s record Q1 saw debt capital markets advisory surge, while restructuring and private capital advisory remained steady, boosted by post-acquisition continuation deals. Bank M&A deal flow slowed on larger transactions despite increased derivative hedging activity, and equity capital markets benefited from outsized healthcare market share unlikely to repeat.
1. Q1 Financial Highlights
Piper Sandler delivered record Q1 revenues driven by strong performance across advisory and capital markets segments. Advisory fees held firm despite a choppy macro backdrop, buoyed by significant healthcare and medtech engagements.
2. Bank M&A and Hedging Trends
Bank M&A closings remained solid on smaller transactions, but pace of larger deals eased from earlier expectations. The derivative desk saw elevated hedging discussions and increased completed transactions, though rate volatility complicated client positioning strategies.
3. Equity Capital Markets and Healthcare Share
The firm captured outsized equity capital markets share in 1Q, particularly in healthcare and industrial sectors, thanks to several larger fee assignments. Management warned that such elevated market share levels are unlikely to persist into Q2.
4. Non-M&A and Debt Capital Markets Advisory
Non-M&A advisory recorded strong results led by a surge in debt capital markets advisory, marking its best quarter since the acquisition. Restructuring and private capital advisory maintained steady contributions, underpinned by a series of continuation transactions.